Varying etiologies lead to different molecular changes in Australian and South African hepatocellular carcinomas

International Journal of Oncology

Volumn 35, Issue 5, 2009, Pages 1081-1089

  Herath, Nirmitha I ^a   Purdie, David M ^a   Kew, Michael C ^b   Smith, Jeffery L ^c   Young, Joanne ^d   Leggett, Barbara A ^d   Macdonald, Graeme A ^a,c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d Royal Brisbane and Womens Hospital Research Foundation   (Australia)

Author keywords

Aflatoxin exposure; Allelic imbalance; Hepatitis B; Hepatocarcinogenesis; Methylation

Indexed keywords

GENE PRODUCT; GENOMIC DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P14; PROTEIN P15; PROTEIN P16; PROTEIN RIZ1; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; AUSTRALIA; CANCER GROWTH; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; FEMALE; GENE FREQUENCY; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SOUTH AFRICA;

ADULT; AGED; ALLELIC IMBALANCE; AUSTRALIA; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SOUTH AFRICA;

EID: 70449574590     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000423     Document Type: Article

References (28)

1. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM and Lotze M: NIH conference; hepatocellular carcinoma. Ann Intern Med 108: 390-401, 1988.
2. Parkin DM, Stjernsward J and Muir CS: Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 62: 163-182, 1984. (Pubitemid 14113756)
3. Hammond C, Jeffers L, Carr Bi and Simon D: Multiple genetic alterations, 4q28, a new suppressor region, and potential gender differences in human hepatocellular carcinoma. Hepatology 29: 1479-1485, 1999. (Pubitemid 29211050)
4. Piao Z, Park C, Park JH and Kim H: Deletion mapping of chromosome 4q in hepatocellular carcinoma. Int J Cancer 79: 356-360, 1998. (Pubitemid 28359732)
5. Fujiwara Y, Ohata H, Emi M, et al: A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer. Genes Chromosomes Cancer 10: 7-14, 1994. (Pubitemid 24137263)
6. Nagai H, Pineau P, Tiollais P, Buendia MA and Dejean A: Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 14: 2927-2933, 1997. (Pubitemid 27315661)
7. Boige V, Laurent-Puig P, Fouchet P, et al: Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res 57: 1986-1990, 1997.
8. Iwata N, Yamamoto H, Sasaki S, et al: Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 19: 5298-5302, 2000.
9. Toyota M, Ahuja N, Ohe-Toyota M, et al: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686, 1999. (Pubitemid 29354851)
10. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K and Asakura H: p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 116: 394-400, 1999. (Pubitemid 29055363)
11. Kanai Y, Ushijima S, Hui AM, et al: The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 71: 355-359, 1997. (Pubitemid 27224296)
12. Wong IH, Lo YM, Yeo W, Lau WY and Johnson PJ: Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res 6: 3516-3521, 2000. (Pubitemid 30694930)
13. Du Y, Carling T, Fang W, et al: Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 61: 8094-8099, 2001. (Pubitemid 33091596)
14. Herath NI, Kew MC, Walsh MD, et al: Reciprocal relationship between methylation status and loss of heterozygosity at the p14ARF locus in Australian and South African hepatocellular carcinomas. J Gastroenterol Hepatol 17: 301-307, 2002.
15. Biden K, Young J, Buttenshaw R, et al: Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population. Hepatology 25: 593-597, 1997. (Pubitemid 27106439)
16. INK4A gene alterations in hepatocellular carcinoma. Oncogene 18: 789-795, 1999.
17. Herranz M, Urioste M, Santos J, et al: Analysis of the INK4a/ARF locus in non-Hodgkin's lymphomas using two new internal microsatellite markers. Leukemia 13: 808-810, 1999. (Pubitemid 29243634)
18. Esteller M, Tortola S, Toyota M, et al: Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 60: 129-133, 2000. (Pubitemid 30058742)
19. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
20. Tamura G, Yin J, Wang S, et al: E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92: 569-573, 2000. (Pubitemid 30212319)
21. Esteller M, Toyota M, Sanchez-Cespedes M, et al: Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G→A mutations in K-ras in colorectal tumorigenesis. Cancer Res 60: 2368-2371, 2000. (Pubitemid 30262424)
22. Xiong Z and Laird PW: COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25: 2532-2534, 1997. (Pubitemid 27303718)
23. Kew MC: Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: evidence from southern Africa. Hepatology 1: 366-369, 1981.
24. Tokino T, Tamura H, Hori N and Matsubara K: Chromosome deletions associated with hepatitis B virus integration. Virology 185: 879-882, 1991.
25. Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R and Hirohashi S: Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis-A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 32: 970-979, 2000. (Pubitemid 30808422)
26. Esteller M, Sanchez-Cespedes M, Rosel LR, et al: Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59: 67-70, 1999. (Pubitemid 29062958)
27. Zochbauer-Muller S, Fong KM, Virmani AK, et al: Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61: 249-255, 2001. (Pubitemid 32095725)
28. Belinsky SA, Nikula KJ, Palmisano WA, et al: Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95: 11891-11896, 1998. (Pubitemid 28460510)